Spondyloarthritis & psoriatic arthritis
A trial-based economic evaluation of the CaFaSpA referral strategy for axial spondyloarthritis
Authors' conclusion
Digital referral did not decrease the overall healthcare status of patients after 1 year of follow-up and appears to be more cost-effective than UC.
Study context
- Population
- Primary care patients with chronic low back pain (CLBP), general practice units in the Netherlands90 GP clusters
- Participants
- 563 patients
- Comparison
- Digital CaFaSpA referral strategy vs usual care
- CSn = 260
- Usual care (UC)n = 303reference
- Primary endpoint
- Cost-utility (incremental cost-utility ratios (ICURs)) for disability (RMDQ) and health-related quality of life (EQ-5D-3L)
- Follow-up
- 12 months
Methodological detailscost-utility analysis, healthcare and societal perspectives, 12-month time horizon
- Cost-utility analysis
- Healthcare and societal perspectives
- 12-month time horizon
Primary result
As reported in the abstract
Incremental cost-utility ratios
ICUR for Roland-Morris Disability Questionnaire (RMDQ), per point decrease
€18,059
ICUR per quality-adjusted life year increase
€220,457
Further findings
Disability (RMDQ) · 12 months
- No minimal important difference in RMDQ
- difference −0.21, 95%CI −1.52 to 1.13 (95%CI)
Health-related quality of life (EQ-5D) · 12 months
- No minimal important difference in EQ-5D
- difference −0.02, 95%CI −0.08 to 0.05 (95%CI)
Original publication
A trial-based economic evaluation of the CaFaSpA referral strategy for axial spondyloarthritis. Scand J Rheumatol. Published 31 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →